Zobrazeno 1 - 1
of 1
pro vyhledávání: '"D. Sayegh"'
Publikováno v:
Journal of Clinical Oncology. 22:2622-2622
2622 Background: ARH460–16-2 is a potent anti-CD44 antibody that has been shown to suppress and delay tumor growth and increase survival in a xenograft model of Her2/neu-negative breast cancer. CD44, a cancer-related membrane glycoprotein, is belie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f0b923b9288f374932b7c2e3dda09e4
https://doi.org/10.1200/jco.2004.22.90140.2622
https://doi.org/10.1200/jco.2004.22.90140.2622
